期刊文献+

2008-2010年我国4个地区HBsAg快检阴性献血者HBV流行率和新发率分析 被引量:5

Investigation on the HBV prevalence and incidence rate among HBsAg rapid testing negative blood donors at four Chinese regions,2008-2010
下载PDF
导出
摘要 目的了解我国不同地区HBsAg快检阴性献血者的HBV流行率、新发率,以综合评估HBV在献血者中的流行情况。方法收集2008年1月-2010年12月昆明、乌鲁木齐、洛阳和柳州4地血站720 885(人)次献血者人口统计学资料、2轮第3代ELISA HBs Ag初筛和确证数据,分别计算初次献血者和重复献血者的HBV流行率,利用文献报道的新发率评估模型,评估重复献血者的新发率。结果 3年间本组4地献血者HBV流行率:0.35%(1 518/435 786)(初次献血者)/0.014%(77/285 099)(重复献血者),其中昆明为0.24%(454/187 540)/0.015%(24/163640)、乌鲁木齐0.52%(463/89 309)/0.022%(22/100 208)、洛阳0.18%(171/94 654)/0.009%(15/175 797)、柳州0.67%(430/64 283)/0.013%(16/124 282);4地重复献血者中的HBV感染总体新发率为1.24‰。结论 4地献血者具有较高的HBV新发率,需采用更灵敏的第4代ELISA试剂和核酸检测,降低4地HBV对血液安全的影响。 Objective To analyze the prevalence and incidence rate of HBV among HBsAg rapid testing negative blood donors at four Chinese regions (Kunming, Urumqi, Luoyang and Liuzhou) from January 2008 to December 2010. Methods The outcomes of parallel screening with the third generation ELISA kits and confirmatory testing results were collected from 720885 donations. The prevalence rates on first and repeat donors were calculated, as well as the incidence rates using the reported incidence evaluation model. Results During the study period, the overall prevalence rates among first and repeat donors were 0. 35% and 0. 014%, among which, the rates (first -time donors/repeat donors) in Kunming, Urumqi, Luoyang and Liuzhou were 0. 24%/0. 015%, 0. 52%/0. 022%, 0. 18%/0. 009% and 0. 67%/0. 013% respectively. The overall HBV incidence rate on repeat donors was 124 per 100 000 donations. Conclusion Relative high HBV incidence rates from these four regions may lead to high HBV transfusion residual risk, and the implementation of fourth generation ELISA screening assays and NAT testing are expected to reduce the impact of HBV on blood safety in China.
出处 《中国输血杂志》 CAS 北大核心 2015年第6期666-668,共3页 Chinese Journal of Blood Transfusion
基金 协和青年基金(33320140190)
关键词 献血者 HBsAg初检阴性 HBV流行率 HBV新发率 Blood Donors HBsAg screening negative HBV prevalence rate HBV incidence rate
  • 相关文献

参考文献18

  • 1Liang X, Bi S, Yang W, et al. Epidemiological serosurvey of hepa- titis B in China-declining HBV prevalence due to hepatitis B vacci- nation. Vaccine, 2009, 27(4): 6550-6557.
  • 2Biswas R, Tabor E, Hsia CC,et al. Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infec- tion. Transfusion, 2003, 43(5): 788-798.
  • 3Ren FR, Wang JX, Huang Y,et al. Hepatitis B virus nucleic acid testing in Chinese blood donors with normal and elevated alanine aminotransferase. Transfusion, 2011,51 ( 3 ) : 2588 -2595.
  • 4Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiolo- gy Donor Study. N Engl J Med, 1996, 334(2) : 1685-1690.
  • 5Korelitz JJ, Busch MP, Kleinman SH,et al. A method for estima- ting hepatitis B virus incidence rates in volunteer blood donors. National Heart, Lung, and Blood Institute Retrovirus Epidemiology Donor Study. Transfusion, 1997, 37(3): 634-640.
  • 6Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control meas- ures. J Viral Hepat, 2004, 11(2): 97-107.
  • 7Zeng P, Wang J, Huang Y,et al. The human immunodeficiency virus-1 genotype diversity and drug resistance mutations profile of volunteer blood donors from Chinese blood centers. Transfusion , 2012, 52(5) : 1041-1049.
  • 8Shan H, Wang JX, Ren FR, et al. Blood banking in China. The Lancet, 2002, 360(4) : 1770-1775.
  • 9Shang G, Seed Clive R, Wang F, et al. Residual risk of transfu- sion-transmitted viral infee6ons in Shenzhen, China, 2001 through 2004. Transfusion, 2007, 47(5): 529-539.
  • 10Zaller N, Nelson KE, Ness P, et al. Demographic characteristics and risks for transfusion-transmissible infection among blood donors in Xinjiang autonomous region, Peoples Republic of China. Trans- fusion, 2006, 46(3) : 265-271.

二级参考文献33

  • 1冯风英,刘仙梅.太原市万柏林区1994—2003年病毒性肝炎流行病学分析[J].山西医药杂志,2004,33(9):755-756. 被引量:2
  • 2杨绍基,任红.传染病学[M].北京:人民卫生出版社,2007,(7):35-37.
  • 3卫生部.2006-2010年全国乙型病毒性肝炎防治规划[R].2006.
  • 4杨锡标 季平 尹桂成.通州市1970~1999年病毒性肝炎流行特征及防制对策.中国初级卫生保健,2000,14(8):34-34.
  • 5Dodd R,Kurt Roth W,Ashford P,et al.Transfusion medicinandsafety.Biologicals,2009,37(1):62-70.
  • 6Glynn SA,Kleinman SH,Wright DJ,et al.International applicationof the incidence rate/window period model.Transfusion,2002,42(8):966-972.
  • 7Correll PK,Law MG,Seed CR,et al.Variant Creutzfeldt-Jakob dis-ease in Australian blood donors:estimation of risk and the impactof deferral strategies.Vox Sang,2001,81(1):6-11.
  • 8Dodd RY,Notari EPt,Stramer SL.Current prevalence and inci-dence of infectious disease markers and estimated window-periodrisk in the American Red Cross blood donor population.Transfu-sion,2002,42(8):975-979.
  • 9Gonzalez M,Regine V,Piccinini V,et al.Residual risk of transfusion-transmitted human immunodeficiency virus,hepatitis C virus,and hep-atitis B virus infections in Italy.Transfusion,2005,45(10):1670-1675.
  • 10Velati C,Romano L,Baruffi L,et al.Residual risk of transfusion-transmitted HCV and HIV infections by antibody-screened blood inItaly.Transfusion,2002,42(8):989-993.

共引文献51

同被引文献38

引证文献5

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部